NNNN
Anbio Biotechnology
$10.18
+$0.28 (+2.83%)Jul 27, 2026
Key metrics
The numbers that frame NNNN today
- Market cap
- $1.46B
- P/E (TTM)
- 228.8
- EV / FCF
- -216.2
- Gross margin
- 87.2%
- EV / Sales
- 168.5
- ROIC
- 46%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $8.30
- 52wk High
- $54.95
Growth
Revenue and earnings trend for NNNN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NNNN
Is Anbio Biotechnology a good buy?
No. Anbio Biotechnology has weak quality and poor momentum. Both signals point to a weaker setup. We think Anbio Biotechnology is selling at a high price.
What is the market capitalization of NNNN?
Anbio Biotechnology's market capitalization is $1.46B.
What is the P/E ratio for NNNN stock?
Anbio Biotechnology's current P/E ratio is 228.8.
What is the 52-week high for NNNN stock?
The 52-week high for Anbio Biotechnology is $54.95. The current close of $10.18 is 81.5% below that high.
What is the 52-week low for NNNN stock?
The 52-week low for Anbio Biotechnology is $8.30. The current close of $10.18 is 22.7% above that low.
Does NNNN stock pay dividends?
Anbio Biotechnology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NNNN?
Anbio Biotechnology's Debt / Equity ratio is 0.